Pharmacotherapy for human immunodeficiency virus-associated nephropathy.

about

Tenofovir renal toxicity targets mitochondria of renal proximal tubules.Pharmacotherapy and treatment options for HIV-associated nephropathy.

P2860

Q33416391-A44FE6A3-405E-4F32-857D-3375122D0D93 Q47567570-3DF2349A-A166-4DE4-8002-D78CD330CEE3

P2860

Pharmacotherapy for human immunodeficiency virus-associated nephropathy.

Item

http://www.wikidata.org/entity/Q36320626

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Pharmacotherapy for human immunodeficiency virus-associated nephropathy.

@ast

Pharmacotherapy for human immunodeficiency virus-associated nephropathy.

@en

type

Item

label

Pharmacotherapy for human immunodeficiency virus-associated nephropathy.

@ast

Pharmacotherapy for human immunodeficiency virus-associated nephropathy.

@en

prefLabel

Pharmacotherapy for human immunodeficiency virus-associated nephropathy.

@ast

Pharmacotherapy for human immunodeficiency virus-associated nephropathy.

@en

P1476

Pharmacotherapy for human immunodeficiency virus-associated nephropathy

@en

P2093

D Byron May

http://www.w3.org/2001/XMLSchema#string

Scott D Pope

http://www.w3.org/2001/XMLSchema#string

P2860

HIVAN and medication use in chronic dialysis patients in the United States: analysis of the USRDS DMMS Wave 2 study

Resolution of organ-specific complications of human immunodeficiency virus infection in children with use of highly active antiretroviral therapy.

HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection.

HIV-associated nephropathy.

Resolution of HIV-associated nephrotic syndrome with highly active antiretroviral therapy delivered by gastrostomy tube.

The nephropathies of HIV infection: pathogenesis and treatment.

Focal segmental glomerulosclerosis in African Americans: effects of steroids and angiotensin converting enzyme inhibitors.

HIV-associated nephropathy: case study and review of the literature.

Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome.

Renal diseases associated with human immunodeficiency virus infection: epidemiology, clinical course, and management.

P304

1761-1772

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1592/PHCO.2005.25.12.1761

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Melissa D. Johnson

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16305296

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy

Pharmacotherapy for human immunodeficiency virus-associated nephropathy.

about

P2860

P2860

Pharmacotherapy for human immunodeficiency virus-associated nephropathy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921